1. Home
  2. IOVA
  3. IOVA News

Latest Iovance Biotherapeutics Inc. (IOVA) News on December 18, 2024

2 Growth Stocks That Could Rocket Higher in 2025: Are They Right for Your Portfolio?
IOVA

Motley Fool

a day ago

2 Growth Stocks That Could Rocket Higher in 2025: Are They Right for Your Portfolio?

Prediction: This Stock Will Beat the Market in 2025
IOVA

Motley Fool

6 days ago

Prediction: This Stock Will Beat the Market in 2025

3 Monster Stocks to Hold for the Next 10 Years
IOVA

Motley Fool

11 days ago

3 Monster Stocks to Hold for the Next 10 Years

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) is a favorite amongst institutional investors who own 63%
IOVA

Simply Wall St.

15 days ago

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) is a favorite amongst institutional investors who own 63%

Is Iovance Biotherapeutics Stock a Millionaire Maker?
IOVA

Motley Fool

21 days ago

Is Iovance Biotherapeutics Stock a Millionaire Maker?

IOVA

MT Newswires

22 days ago

Iovance Biotherapeutics Names Raj Puri as Chief Regulatory Officer

Iovance Biotherapeutics Announces the Promotion of Raj Puri, M.D., Ph.D. to Chief Regulatory Officer
IOVA

GlobeNewswire

22 days ago

Iovance Biotherapeutics Announces the Promotion of Raj Puri, M.D., Ph.D. to Chief Regulatory Officer

Got $1,500? Buy Iovance Biotherapeutics Now and Don't Look Back
IOVA

Motley Fool

25 days ago

Got $1,500? Buy Iovance Biotherapeutics Now and Don't Look Back

Iovance Biotherapeutics, Inc. (IOVA): Among the Most Promising Cancer Stocks According to Hedge Funds
IOVA

Insider Monkey

25 days ago

Iovance Biotherapeutics, Inc. (IOVA): Among the Most Promising Cancer Stocks According to Hedge Funds

2 Innovative Stocks That Could Deliver Outsize Returns
IOVA

Motley Fool

a month ago

2 Innovative Stocks That Could Deliver Outsize Returns

Iovance Biotherapeutics Inc. (IOVA): Among the NASDAQ Stocks with Biggest Upside Potential According to Analysts
IOVA

Insider Monkey

a month ago

Iovance Biotherapeutics Inc. (IOVA): Among the NASDAQ Stocks with Biggest Upside Potential According to Analysts

Iovance Biotherapeutics Third Quarter 2024 Earnings: Beats Expectations
IOVA

Simply Wall St.

a month ago

Iovance Biotherapeutics Third Quarter 2024 Earnings: Beats Expectations

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year
IOVA

Simply Wall St.

a month ago

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year

IOVA Posts Narrower-Than-Expected Q3 Loss, Amtagvi Sales Drive Top line
IOVA

Zacks

a month ago

IOVA Posts Narrower-Than-Expected Q3 Loss, Amtagvi Sales Drive Top line

Iovance Biotherapeutics Inc (IOVA) Q3 2024 Earnings Call Highlights: Surpassing Revenue ...
IOVA

GuruFocus.com

a month ago

Iovance Biotherapeutics Inc (IOVA) Q3 2024 Earnings Call Highlights: Surpassing Revenue ...

Iovance Biotherapeutics (IOVA) Reports Q3 Loss, Tops Revenue Estimates
IOVA

Zacks

a month ago

Iovance Biotherapeutics (IOVA) Reports Q3 Loss, Tops Revenue Estimates

IOVA

Associated Press Finance

a month ago

Iovance Biotherapeutics: Q3 Earnings Snapshot

Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Third Quarter and Year to Date 2024
IOVA

GlobeNewswire

a month ago

Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Third Quarter and Year to Date 2024

High Growth Tech Stocks to Watch in November 2024
IOVA

Simply Wall St.

a month ago

High Growth Tech Stocks to Watch in November 2024

Iovance Biotherapeutics to Host Third Quarter and Year-to-Date 2024 Financial Results Conference Call and Webcast on Thursday, November 7, 2024
IOVA

GlobeNewswire

2 months ago

Iovance Biotherapeutics to Host Third Quarter and Year-to-Date 2024 Financial Results Conference Call and Webcast on Thursday, November 7, 2024

Why Iovance Biotherapeutics Stock Triumphed on Thursday
IOVA

Motley Fool

2 months ago

Why Iovance Biotherapeutics Stock Triumphed on Thursday

IOVA

MT Newswires

2 months ago

UBS Initiates Iovance Biotherapeutics With Buy Rating, $17 Price Target

State Street Corp's Strategic Acquisition in Iovance Biotherapeutics Inc
IOVA

GuruFocus.com

2 months ago

State Street Corp's Strategic Acquisition in Iovance Biotherapeutics Inc

Is Iovance Biotherapeutics Inc. (IOVA) the Most Promising Stock to Buy According to Wall Street Analysts?
IOVA

Insider Monkey

2 months ago

Is Iovance Biotherapeutics Inc. (IOVA) the Most Promising Stock to Buy According to Wall Street Analysts?

Is Iovance Biotherapeutics, Inc. (IOVA) the Best Growth Stock Under $10 to Buy?
IOVA

Insider Monkey

2 months ago

Is Iovance Biotherapeutics, Inc. (IOVA) the Best Growth Stock Under $10 to Buy?

Is Iovance Biotherapeutics, Inc. (IOVA) the Best Stock Under $10 With High Potential?
IOVA

Insider Monkey

2 months ago

Is Iovance Biotherapeutics, Inc. (IOVA) the Best Stock Under $10 With High Potential?

Strong Investor Sentiment: Artisan Partners Highlights Iovance Biotherapeutics, Inc. (IOVA)
IOVA

Insider Monkey

2 months ago

Strong Investor Sentiment: Artisan Partners Highlights Iovance Biotherapeutics, Inc. (IOVA)

Is Iovance Biotherapeutics Stock a Buy?
IOVA

Motley Fool

2 months ago

Is Iovance Biotherapeutics Stock a Buy?

High Growth Tech Stocks to Watch in October 2024
IOVA

Simply Wall St.

3 months ago

High Growth Tech Stocks to Watch in October 2024

3 Reasons to Buy Iovance Biotherapeutics Stock Like There's No Tomorrow
IOVA

Motley Fool

3 months ago

3 Reasons to Buy Iovance Biotherapeutics Stock Like There's No Tomorrow

Iovance Biotherapeutics (NASDAQ:IOVA) delivers shareholders favorable 74% return over 1 year, surging 4.9% in the last week alone
IOVA

Simply Wall St.

3 months ago

Iovance Biotherapeutics (NASDAQ:IOVA) delivers shareholders favorable 74% return over 1 year, surging 4.9% in the last week alone

3 Things You Need to Know if You Buy Iovance Biotherapeutics Today
IOVA

Motley Fool

3 months ago

3 Things You Need to Know if You Buy Iovance Biotherapeutics Today

Iovance Biotherapeutics, Inc. (IOVA): Short Seller Sentiment is Bearish on This Cancer Stock
IOVA

Insider Monkey

3 months ago

Iovance Biotherapeutics, Inc. (IOVA): Short Seller Sentiment is Bearish on This Cancer Stock

Alimera Sciences (ALIM) Soars 6.6%: Is Further Upside Left in the Stock?
IOVA

Zacks

3 months ago

Alimera Sciences (ALIM) Soars 6.6%: Is Further Upside Left in the Stock?

This Is the Biggest Risk With Iovance Biotherapeutics Stock
IOVA

Motley Fool

3 months ago

This Is the Biggest Risk With Iovance Biotherapeutics Stock

Iovance Biotherapeutics to Present at Upcoming Conferences
IOVA

GlobeNewswire

3 months ago

Iovance Biotherapeutics to Present at Upcoming Conferences

3 Monster Biotech Stocks to Buy Before 2025
IOVA

Motley Fool

4 months ago

3 Monster Biotech Stocks to Buy Before 2025

Up 47% in 2024: Where Will Iovance Biotherapeutics Be in 5 Years?
IOVA

Motley Fool

4 months ago

Up 47% in 2024: Where Will Iovance Biotherapeutics Be in 5 Years?

High Growth Tech Stocks To Watch In August 2024
IOVA

Simply Wall St.

4 months ago

High Growth Tech Stocks To Watch In August 2024

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
IOVA

GlobeNewswire

4 months ago

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

This 1 Big Risk Is Also 1 Big Opportunity for Iovance Biotherapeutics Stock
IOVA

Motley Fool

4 months ago

This 1 Big Risk Is Also 1 Big Opportunity for Iovance Biotherapeutics Stock

Industry Analysts Just Made A Sizeable Upgrade To Their Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Revenue Forecasts
IOVA

Simply Wall St.

4 months ago

Industry Analysts Just Made A Sizeable Upgrade To Their Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Revenue Forecasts

3 US Growth Companies With High Insider Ownership Growing Earnings Up To 68%
IOVA

Simply Wall St.

4 months ago

3 US Growth Companies With High Insider Ownership Growing Earnings Up To 68%

Iovance Biotherapeutics Second Quarter 2024 Earnings: Beats Expectations
IOVA

Simply Wall St.

4 months ago

Iovance Biotherapeutics Second Quarter 2024 Earnings: Beats Expectations

Why Iovance Biotherapeutics Shares Are Soaring Today
IOVA

Motley Fool

4 months ago

Why Iovance Biotherapeutics Shares Are Soaring Today

Iovance (IOVA) Q2 Earnings Beat, Stock Up on Upbeat Sales View
IOVA

Zacks

4 months ago

Iovance (IOVA) Q2 Earnings Beat, Stock Up on Upbeat Sales View

Iovance Biotherapeutics (IOVA) Reports Q2 Loss, Tops Revenue Estimates
IOVA

Zacks

4 months ago

Iovance Biotherapeutics (IOVA) Reports Q2 Loss, Tops Revenue Estimates

IOVA

Associated Press Finance

4 months ago

Iovance Biotherapeutics: Q2 Earnings Snapshot

Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Second Quarter and First Half 2024
IOVA

GlobeNewswire

4 months ago

Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Second Quarter and First Half 2024

Kronos Bio, Inc. (KRON) Expected to Beat Earnings Estimates: Should You Buy?
IOVA

Zacks

4 months ago

Kronos Bio, Inc. (KRON) Expected to Beat Earnings Estimates: Should You Buy?

AquaBounty Technologies, Inc. (AQB) Reports Q2 Loss, Tops Revenue Estimates
IOVA

Zacks

4 months ago

AquaBounty Technologies, Inc. (AQB) Reports Q2 Loss, Tops Revenue Estimates

Iovance Biotherapeutics (IOVA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
IOVA

Zacks

5 months ago

Iovance Biotherapeutics (IOVA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Bullish Iovance Biotherapeutics Insiders Loaded Up On US$74.9m Of Stock
IOVA

Simply Wall St.

5 months ago

Bullish Iovance Biotherapeutics Insiders Loaded Up On US$74.9m Of Stock

Iovance Biotherapeutics Attracted a Downgrade. Is It Time to Sell?
IOVA

Motley Fool

5 months ago

Iovance Biotherapeutics Attracted a Downgrade. Is It Time to Sell?

Why Iovance Biotherapeutics Stock Stumbled Today
IOVA

Motley Fool

5 months ago

Why Iovance Biotherapeutics Stock Stumbled Today

Iovance Biotherapeutics to Host Second Quarter and First Half 2024 Financial Results Conference Call and Webcast on Thursday, August 8, 2024
IOVA

GlobeNewswire

5 months ago

Iovance Biotherapeutics to Host Second Quarter and First Half 2024 Financial Results Conference Call and Webcast on Thursday, August 8, 2024

Here’s Why Iovance Biotherapeutics (IOVA) Declined in Q2
IOVA

Insider Monkey

5 months ago

Here’s Why Iovance Biotherapeutics (IOVA) Declined in Q2

IOVA

MT Newswires

5 months ago

Piper Sandler Downgrades Iovance Biotherapeutics to Neutral From Overweight, Adjusts Price Target to $10 From $19; Shares Fall

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
IOVA

Zacks

5 months ago

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
IOVA

GlobeNewswire

5 months ago

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
IOVA

Zacks

5 months ago

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

Is Iovance Biotherapeutics a Millionaire Maker?
IOVA

Motley Fool

5 months ago

Is Iovance Biotherapeutics a Millionaire Maker?

Is Iovance Biotherapeutics, Inc. (IOVA) One of the Most Shorted Stocks Loved by Analysts?
IOVA

Insider Monkey

5 months ago

Is Iovance Biotherapeutics, Inc. (IOVA) One of the Most Shorted Stocks Loved by Analysts?

Unveiling Three US Growth Companies With High Insider Ownership
IOVA

Simply Wall St.

6 months ago

Unveiling Three US Growth Companies With High Insider Ownership

IOVA

MT Newswires

6 months ago

Iovance Biotherapeutics Seeks European Regulator's Approval of Marketing Authorization Application for Advanced Melanoma Treatment

Iovance Biotherapeutics Submits Marketing Authorization Application to European Medicines Agency for Lifileucel in Advanced Melanoma
IOVA

GlobeNewswire

6 months ago

Iovance Biotherapeutics Submits Marketing Authorization Application to European Medicines Agency for Lifileucel in Advanced Melanoma

Is It Too Late to Buy Iovance Biotherapeutics Stock?
IOVA

Motley Fool

6 months ago

Is It Too Late to Buy Iovance Biotherapeutics Stock?

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
IOVA

GlobeNewswire

6 months ago

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

IOVA

MT Newswires

6 months ago

JMP Securities Adjusts Price Target on Iovance Biotherapeutics to $23 From $25, Maintains Market Outperform Rating

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse
IOVA

PR Newswire

6 months ago

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

Seibu Ikebukuro Main Store Slated for Summer 2025 Grand Re-opening as a New Department Store
IOVA

Business Wire

6 months ago

Seibu Ikebukuro Main Store Slated for Summer 2025 Grand Re-opening as a New Department Store

New Zealand scraps plan to tax livestock burps, farts
IOVA

AFP

6 months ago

New Zealand scraps plan to tax livestock burps, farts

IOVA

Business Wire

6 months ago

InnoCare Announces Clearance of Clinical Trial of TYK2 Inhibitor ICP-332 by U.S. FDA

ECB’s Lagarde Sees Multi-Meeting Rate Holds A Possibility
IOVA

The Wall Street Journal

6 months ago

ECB’s Lagarde Sees Multi-Meeting Rate Holds A Possibility

UK Unemployment Rises in Sign Inflationary Pressures Cool
IOVA

Bloomberg

6 months ago

UK Unemployment Rises in Sign Inflationary Pressures Cool

Insider-Owned Growth Companies On The Chinese Exchange In June 2024
IOVA

Simply Wall St.

6 months ago

Insider-Owned Growth Companies On The Chinese Exchange In June 2024

Here's Why New Toyo International Holdings (SGX:N08) Has Caught The Eye Of Investors
IOVA

Simply Wall St.

6 months ago

Here's Why New Toyo International Holdings (SGX:N08) Has Caught The Eye Of Investors

The Case for Buying Iovance Biotherapeutics Stock Just Got Even Better. Here's Why
IOVA

Motley Fool

6 months ago

The Case for Buying Iovance Biotherapeutics Stock Just Got Even Better. Here's Why

Exploring Three US Growth Companies With Substantial Insider Ownership
IOVA

Simply Wall St.

7 months ago

Exploring Three US Growth Companies With Substantial Insider Ownership

Iovance Biotherapeutics to Present at Upcoming Conferences and Events
IOVA

GlobeNewswire

7 months ago

Iovance Biotherapeutics to Present at Upcoming Conferences and Events

Iovance (IOVA) Up 5% on Updated Data From Melanoma Study
IOVA

Zacks

7 months ago

Iovance (IOVA) Up 5% on Updated Data From Melanoma Study

Iovance Biotherapeutics Announces Clinical Data in Frontline Advanced Melanoma at ASCO 2024 Annual Meeting
IOVA

GlobeNewswire

7 months ago

Iovance Biotherapeutics Announces Clinical Data in Frontline Advanced Melanoma at ASCO 2024 Annual Meeting

Bull Market Buys: 2 Growth Stocks to Own for the Long Run
IOVA

Motley Fool

7 months ago

Bull Market Buys: 2 Growth Stocks to Own for the Long Run

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
IOVA

GlobeNewswire

7 months ago

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

4 Small-Cap Value Stocks That Could Go Parabolic
IOVA

Motley Fool

7 months ago

4 Small-Cap Value Stocks That Could Go Parabolic

IOVA

MT Newswires

7 months ago

Truist Securities Trims Iovance Biotherapeutics' Price Target to $25 From $26, Buy Rating Maintained

IOVA

MT Newswires

7 months ago

Truist Adjusts Iovance Biotherapeutics' Price Target to $25 From $26, Keeps Buy Rating

Why Iovance Stock Is Down 18% Today
IOVA

Motley Fool

7 months ago

Why Iovance Stock Is Down 18% Today

IOVA

MT Newswires

7 months ago

Iovance Biotherapeutics' Patient Selection for Amtagvi Launch Minimizing Attrition, Truist Securities Says

Iovance Biotherapeutics Inc (IOVA) Q1 2024 Earnings: Aligns with EPS Projections Amidst Strong ...
IOVA

GuruFocus.com

7 months ago

Iovance Biotherapeutics Inc (IOVA) Q1 2024 Earnings: Aligns with EPS Projections Amidst Strong ...

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q1 2024 Earnings Call Transcript
IOVA

Insider Monkey

7 months ago

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q1 2024 Earnings Call Transcript

IOVA

MT Newswires

7 months ago

Update: Iovance Biotherapeutics Shares Fall After Q1 Revenue Misses Estimates

Iovance (IOVA) Q1 Earnings Surpass, Sales Lag Estimates
IOVA

Zacks

7 months ago

Iovance (IOVA) Q1 Earnings Surpass, Sales Lag Estimates

IOVA

Associated Press Finance

7 months ago

Iovance Biotherapeutics: Q1 Earnings Snapshot

IOVA

MT Newswires

7 months ago

Iovance Biotherapeutics Q1 Loss Narrows -- Shares Higher After Hours

Iovance Biotherapeutics Reports First Quarter 2024 Financial Results and Corporate Updates
IOVA

GlobeNewswire

7 months ago

Iovance Biotherapeutics Reports First Quarter 2024 Financial Results and Corporate Updates

Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?
IOVA

Zacks

7 months ago

Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?

Iovance (IOVA) Gears Up for Q1 Earnings: Here's What to Expect
IOVA

Zacks

7 months ago

Iovance (IOVA) Gears Up for Q1 Earnings: Here's What to Expect

Iovance Biotherapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Thursday, May 9, 2024
IOVA

GlobeNewswire

8 months ago

Iovance Biotherapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Thursday, May 9, 2024

Iovance Biotherapeutics to Present at Upcoming Conferences
IOVA

GlobeNewswire

8 months ago

Iovance Biotherapeutics to Present at Upcoming Conferences

Share on Social Networks: